Alpesh Patel, MD, director of the spine surgery fellowship and co-director of the Northwestern Spine Center in Chicago, discusses the key trends for orthopedics in 2019 and where he sees the biggest opportunity for growth.
Biologics
Alejandro Badia, MD, is using the BioPro Modular Thumb Implant to treat basal joint arthritis.
MTF Biologics awarded 10 researchers more than $1.6 million in funding through its 2018 Research Grant Program.
The California Institute for Regenerative Medicine in Oakland awarded a $5.6 million research grant to UC Davis Health researchers Diana Farmer, MD, and Aijun Wang, PhD, for their work on stem cell therapies for spina bifida.
In 2018, Kuros Biosciences recorded the first sales of its MagnetOs bone graft substitute in the U.S. and Europe and raised capital to fund a phase 2 clinical trial of its spinal fusion product.
Advertisement
Sharonville, Ohio-based Beacon Orthopaedics & Sports Medicine is offering orthobiologic and regenerative medicine treatment options for patients with neck and spine pain, Fox19.com reports.
Royal Biologics is an orthobiologics company focused on regenerative cellular technology.
The FDA plans to crackdown on unsubstantiated and poor quality stem cell therapies in 2019, Law 360 reports.
Axolotl Biologix released the Axolotl Shot, a syringe preloaded with ambient temperature regenerative fluid that physicians can apply to patients during same-day, outpatient visits.
Dakota Dunes, S.D.-based Center for Neurosciences, Orthopaedics & Spine physicians have used platelet rich plasma injections to treat more than 100 joint pain patients, according to KTIV News.